主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Entities affiliated with Viking Global Investors LP | 是 | 524.70万 | 9.00% | 新增 | 新增 | -- |
| 2 | Entities affiliated with Versant Venture Capital VII, L.P. | 是 | 515.48万 | 8.80% | 新增 | 新增 | -- |
| 3 | Robert Adelman,Corey Goodman | 否 | 515.48万 | 8.80% | 新增 | 新增 | -- |
机构持股汇总
| 主力进出\报告期 | 2024-02-26 | 2024-02-16 | 2024-02-15 | 2024-02-14 | 2024-02-13 | 2024-02-12 |
|---|---|---|---|---|---|---|
| 机构数量(家) | 123 | 123 | 123 | 120 | 96 | 85 |
| 累计持有数量(万股) | 5436.81 | 5539.06 | 5436.81 | 5418.47 | 5412.49 | 5361.30 |
| 累计市值(亿) | 33.97 | 34.58 | 33.93 | 33.82 | 33.77 | 33.45 |
| 持仓比例(%) | 89.13% | 90.80% | 89.13% | 88.83% | 88.73% | 87.89% |
| 净交易量(万股) |
注:若当期数据无主力机构持仓或公司定期报告未披露完毕,则不显示。
非主要股东机构持股变动
| 机构或基金名称 | 持有数量 | 持股市值(亿美元) | 持股变动(万股) | 变动比例(%) |
|---|---|---|---|---|
|
Abg-wtt Global Life Science Capital Partners Gp Ltd
|
77.89万股 | - | - | 不足0.01 |
|
Alliancebernstein L.P.
|
93.89万股 | - | -29.58 | -23.96 |
|
Blackrock Inc.
|
136.88万股 | - | 135.88 | 13588.38 |
|
Cormorant Asset Management, Lp
|
121.35万股 | - | 3.12 | 2.64 |
|
Deerfield Management Company, L.P.
|
100.61万股 | - | -15.30 | -13.20 |
|
Fairmount Funds Management Llc
|
124.59万股 | - | 2.40 | 1.97 |
|
Hhlr Advisors, Ltd.
|
106.24万股 | - | -33.33 | -23.88 |
|
Laurion Capital Management Lp
|
77.19万股 | - | -20.00 | -20.58 |
|
Orbimed Advisors Llc
|
236.52万股 | - | -25.77 | -9.83 |
|
Redmile Group, Llc
|
185.77万股 | - | - | 不足0.01 |
|
Samsara Biocapital, Llc
|
184.59万股 | - | - | 不足0.01 |
|
Sofinnova Investments, Inc.
|
241.95万股 | - | - | 不足0.01 |
|
Sands Capital Ventures, Llc
|
77.89万股 | - | -41.67 | -34.85 |
|
Tcg Crossover Management, Llc
|
86.99万股 | - | - | 不足0.01 |
|
Versant Venture Management, Llc
|
515.82万股 | - | - | 不足0.01 |
|
Venbio Partners Llc
|
515.82万股 | - | - | 不足0.01 |
|
Viking Global Investors Lp
|
664.27万股 | - | - | 不足0.01 |
|
Vr Adviser, Llc
|
403.05万股 | - | 1.36 | 0.34 |
|
Vanguard Group Inc
|
117.00万股 | - | 112.00 | 2239.97 |
| 机构或基金名称 | 持有数量 | 持股市值(亿美元) | 持股变动(万股) | 变动比例(%) |
|---|---|---|---|---|
|
Alliancebernstein L.P.
|
93.89万股 | - | -29.58 | -23.96 |
|
Abg-wtt Global Life Science Capital Partners Gp Ltd
|
77.89万股 | - | - | 不足0.01 |
|
Blackrock Inc.
|
136.88万股 | - | 135.88 | 13588.38 |
|
Deerfield Management Company, L.P.
|
100.61万股 | - | -15.30 | -13.20 |
|
Cormorant Asset Management, Lp
|
121.35万股 | - | 3.12 | 2.64 |
|
Fairmount Funds Management Llc
|
124.59万股 | - | 2.40 | 1.97 |
|
Hhlr Advisors, Ltd.
|
106.24万股 | - | -33.33 | -23.88 |
|
Laurion Capital Management Lp
|
77.19万股 | - | -20.00 | -20.58 |
|
Orbimed Advisors Llc
|
236.52万股 | - | -25.77 | -9.83 |
|
Redmile Group, Llc
|
185.77万股 | - | - | 不足0.01 |
|
Sands Capital Ventures, Llc
|
77.89万股 | - | -41.67 | -34.85 |
|
Sofinnova Investments, Inc.
|
241.95万股 | - | - | 不足0.01 |
|
Samsara Biocapital, Llc
|
184.59万股 | - | - | 不足0.01 |
|
Tcg Crossover Management, Llc
|
86.99万股 | - | - | 不足0.01 |
|
Venbio Partners Llc
|
515.82万股 | - | - | 不足0.01 |
|
Vanguard Group Inc
|
117.00万股 | - | 112.00 | 2239.97 |
|
Versant Venture Management, Llc
|
515.82万股 | - | - | 不足0.01 |
|
Viking Global Investors Lp
|
664.27万股 | - | - | 不足0.01 |
| 机构或基金名称 | 持有数量 | 持股市值(亿美元) | 持股变动(万股) | 变动比例(%) |
|---|---|---|---|---|
|
Alpine Associates Management Inc.
|
76.29万股 | - | 76.29 | 不足0.01 |
| 机构或基金名称 | 持有数量 | 持股市值(亿美元) | 持股变动(万股) | 变动比例(%) |
|---|---|---|---|---|
|
Alliancebernstein L.P.
|
123.46万股 | - | 123.46 | 不足0.01 |
|
Capital Research Global Investors
|
125.00万股 | - | 125.00 | 不足0.01 |
|
Deerfield Management Company, L.P.
|
115.91万股 | - | 115.91 | 不足0.01 |
|
Fairmount Funds Management Llc
|
122.19万股 | - | 122.19 | 不足0.01 |
|
Cormorant Asset Management, Lp
|
118.23万股 | - | 118.23 | 不足0.01 |
|
Fmr Llc
|
113.90万股 | - | 113.90 | 不足0.01 |
|
Laurion Capital Management Lp
|
97.19万股 | - | 97.19 | 不足0.01 |
|
Hhlr Advisors, Ltd.
|
139.57万股 | - | 139.57 | 不足0.01 |
|
Redmile Group, Llc
|
185.77万股 | - | 185.77 | 不足0.01 |
|
Sands Capital Ventures, Llc
|
119.56万股 | - | 119.56 | 不足0.01 |
|
Samsara Biocapital, Llc
|
184.59万股 | - | 184.59 | 不足0.01 |
|
Sofinnova Investments, Inc.
|
241.95万股 | - | 241.95 | 不足0.01 |
|
Orbimed Advisors Llc
|
262.29万股 | - | 262.29 | 不足0.01 |
|
Price T Rowe Associates Inc
|
103.36万股 | - | 103.36 | 不足0.01 |
|
Viking Global Investors Lp
|
664.27万股 | - | 664.27 | 不足0.01 |
|
Vr Adviser, Llc
|
401.68万股 | - | 401.68 | 不足0.01 |
|
Versant Venture Management, Llc
|
515.82万股 | - | 515.82 | 不足0.01 |
|
Venbio Partners Llc
|
515.82万股 | - | 515.82 | 不足0.01 |
|
Wellington Management Group Llp
|
387.62万股 | - | 387.62 | 不足0.01 |
|
Tcg Crossover Management, Llc
|
86.99万股 | - | 86.99 | 不足0.01 |
| 机构或基金名称 | 持有数量 | 持股市值(亿美元) | 持股变动(万股) | 变动比例(%) |
|---|---|---|---|---|
|
Alliancebernstein L.P.
|
123.46万股 | - | 123.46 | 不足0.01 |
|
Capital Research Global Investors
|
125.00万股 | - | 125.00 | 不足0.01 |
|
Fairmount Funds Management Llc
|
122.19万股 | - | 122.19 | 不足0.01 |
|
Deerfield Management Company, L.P.
|
115.91万股 | - | 115.91 | 不足0.01 |
|
Cormorant Asset Management, Lp
|
118.23万股 | - | 118.23 | 不足0.01 |
|
Hhlr Advisors, Ltd.
|
139.57万股 | - | 139.57 | 不足0.01 |
|
Fmr Llc
|
113.90万股 | - | 113.90 | 不足0.01 |
|
Laurion Capital Management Lp
|
97.19万股 | - | 97.19 | 不足0.01 |
|
Orbimed Advisors Llc
|
262.29万股 | - | 262.29 | 不足0.01 |
|
Samsara Biocapital, Llc
|
184.59万股 | - | 184.59 | 不足0.01 |
|
Sands Capital Ventures, Llc
|
119.56万股 | - | 119.56 | 不足0.01 |
|
Price T Rowe Associates Inc
|
103.36万股 | - | 103.36 | 不足0.01 |
|
Redmile Group, Llc
|
185.77万股 | - | 185.77 | 不足0.01 |
|
Sofinnova Investments, Inc.
|
241.95万股 | - | 241.95 | 不足0.01 |
|
Tcg Crossover Management, Llc
|
86.99万股 | - | 86.99 | 不足0.01 |
|
Versant Venture Management, Llc
|
515.82万股 | - | 515.82 | 不足0.01 |
|
Wellington Management Group Llp
|
387.62万股 | - | 387.62 | 不足0.01 |
|
Vr Adviser, Llc
|
401.68万股 | - | 401.68 | 不足0.01 |
|
Venbio Partners Llc
|
515.82万股 | - | 515.82 | 不足0.01 |
|
Viking Global Investors Lp
|
664.27万股 | - | 664.27 | 不足0.01 |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2024-01-22 | Moran Susan |
|
32.26 | 3.24 | 是 | CHIEF MEDICAL OFFICER |
| 2023-09-19 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. |
|
155.78 | -- | 是 | -- |
| 2023-09-19 | venBio Global Strategic Fund III, L.P. |
|
515.82 | -- | 是 | -- |
| 2023-09-19 | venBio Global Strategic Fund III, L.P. |
|
378.70 | -- | 是 | -- |
| 2023-09-19 | venBio Global Strategic Fund III, L.P. |
|
491.08 | -- | 是 | -- |